Metabolomic Profiling of the Effects of Dapagliflozin in Patients With HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF
Circulation 2022 May 23;[EPub Ahead of Print], S Selvaraj, Z Fu, P Jones, LC Kwee, SL Windsor, O Ilkayeva, CB Newgard, KB Margulies, M Husain, SE Inzucchi, DK McGuire, B Pitt, BM Scirica, DE Lanfear, ME Nassif, A Javaheri, RJ Mentz, MN Kosiborod, SH ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.